Form: 6-K

Report of foreign issuer [Rules 13a-16 and 15d-16]

November 19, 2026

 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the Month of November 2026

Commission File Number: 001-38607

 

 

ENDAVA PLC

(Name of Registrant)

 

 

125 Old Broad Street

London EC2N 1AR

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: ☒ Form 20-F ☐  Form 40-F

 

 
 


NYSE Notice of Noncompliance

On November 18, 2026, Endava plc (the “Company”) received a notice of noncompliance from the New York Stock Exchange (the “NYSE”) noting that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual, Annual and Quarterly Report Timely Filing Criteria, due to the delayed filing of the Company’s Annual Report on Form 20-F for the fiscal year ended June 30, 2026 (the “Annual Report”).

The NYSE has informed the Company that it has up to six months from the filing due date of November 17, 2026 to file the Annual Report to regain compliance (the “Initial Cure Period”). If the Company does not regain compliance within the Initial Cure Period, the NYSE may, in its sole discretion, grant an additional period of up to six months, or may determine to commence suspension and delisting procedures. The Company intends to file the Annual Report and regain compliance within the Initial Cure Period; however, there can be no assurance that the Company will ultimately regain compliance with all applicable NYSE listing standards.

On November 19, 2026, the Company issued a press release announcing its receipt of the NYSE notice. A copy of the press release is furnished as Exhibit 99.1 to this Form 6-K and is incorporated herein by reference.

INCORPORATION BY REFERENCE

Exhibit 99.1 is hereby expressly incorporated by reference into the Company’s registration statement on Form F-3 (File No. 333-229213) and registration statements on Form S-8 (File Nos. 333-228717, 333-248904, 333-259900, 333-268067, 333-274571, 333-282207 and 333-290043), and any related prospectuses, as such registration statements may be amended from time to time, and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

EXHIBIT LIST

 

Exhibit

  

Description

99.1    Press Release, dated November 19, 2026


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

   

ENDAVA PLC

Date: November 19, 2026     By:   /s/ Conor McShane
     

Name: Conor McShane

     

Title: Interim Chief Financial Officer